Potential Benefits of Psilocybin for Lupus Pain: A Case Report

Author:

Gonzales Sofia Audrey B.1,Alexopoulos Christine1,Arkfeld Daniel G.1

Affiliation:

1. Department of Rheumatology, University of Southern California, 1520 San Pablo St Los Angeles, CA90033-5310, United States

Abstract

Introduction: Outcomes of treatment for patients with Lupus have shown overall improvement and benefit from the more aggressive use of immunosuppressants and biological agents through a treat-to-target approach. However, chronic musculoskeletal pain can be refractory to treatment despite the use of non-steroidal anti-inflammatory drugs, corticosteroids, and other analgesic agents, leading to patient dissatisfaction. The concept of new neural pathways from psilocybin usage has been proposed in a variety of pain syndromes; however, it is not trialed for patients with Lupus pain. Case Presentation: The patient was a 67-year-old male with positive anti-dsDNA antibody Lupus with a predominance of chronic polyarticular joint pain treated with hydroxychloroquine and non-steroidal anti-inflammatory drugs without pain relief. Pain dramatically improved after a one-time macro-dosing of 6 grams of Psilocybin cubensis in Oregon, which he expected would only provide a sense of enlightenment. After 12 months, he continued without debilitating joint pain. Conclusion: The serotonin-2A receptor’s activation triggers an array of neurophysiological reactions that disrupt the functional connections in areas of the brain that are associated with chronic pain. These neuroplastic effects can generate healthy connections, resulting in long-lasting pain relief. However, this is a process that has not been fully analyzed. While there is anecdotal evidence to suggest the therapeutic benefits for autoimmune diseases, including rheumatoid arthritis and psoriasis, there is no specific research that explores its use for lupus-related pain. Since this is the first case that shows the benefit of psilocybin in a patient with Lupus, further studies on macro-dosing psilocybin to treat Lupus pain are warranted.

Publisher

Bentham Science Publishers Ltd.

Subject

Rheumatology

Reference14 articles.

1. Ghlichloo I.; Gerriets V.; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Florida: StatPearls

2. Marcum Z.A.; Hanlon J.T.; Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults. Ann Longterm Care 2010,18(9),24-27

3. Dinis-Oliveira R.J.; Metabolism of psilocybin and psilocin: Clinical and forensic toxicological relevance. Drug Metab Rev 2017,49(1),84-91

4. Aronson J.K.; Manson's Tropical Infectious Diseases. Amsterdam: Elsevier Limited 2014.

5. Lowe H.; Toyang N.; Steele B.; Valentine H.; Grant J.; Ali A.; Ngwa W.; Gordon L.; The therapeutic potential of psilocybin. Molecules 2021,26(10),2948

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3